TORBICA, ALEKSANDRA
 Distribuzione geografica
Continente #
EU - Europa 10.023
NA - Nord America 4.667
AS - Asia 1.898
SA - Sud America 192
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 6
Totale 16.872
Nazione #
IT - Italia 6.069
US - Stati Uniti d'America 4.434
IE - Irlanda 964
GB - Regno Unito 723
SG - Singapore 581
CN - Cina 533
UA - Ucraina 401
DE - Germania 380
RU - Federazione Russa 305
SE - Svezia 247
NL - Olanda 219
CA - Canada 212
TR - Turchia 189
BR - Brasile 162
FI - Finlandia 160
FR - Francia 159
HK - Hong Kong 139
VN - Vietnam 122
BG - Bulgaria 64
KR - Corea 63
IL - Israele 57
IN - India 52
BE - Belgio 51
DK - Danimarca 49
ID - Indonesia 48
ES - Italia 34
CZ - Repubblica Ceca 27
AL - Albania 25
CH - Svizzera 25
RO - Romania 25
AT - Austria 20
TN - Tunisia 20
EU - Europa 18
IR - Iran 18
GR - Grecia 17
TH - Thailandia 16
MA - Marocco 12
PL - Polonia 11
PT - Portogallo 11
EG - Egitto 10
JP - Giappone 10
PH - Filippine 8
AE - Emirati Arabi Uniti 7
LV - Lettonia 7
MX - Messico 7
PK - Pakistan 7
AZ - Azerbaigian 6
EC - Ecuador 6
PE - Perù 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
AR - Argentina 5
NI - Nicaragua 5
AU - Australia 4
BO - Bolivia 4
GE - Georgia 4
KE - Kenya 4
KZ - Kazakistan 4
LK - Sri Lanka 4
LS - Lesotho 4
MY - Malesia 4
NO - Norvegia 4
PA - Panama 4
BY - Bielorussia 3
DZ - Algeria 3
HU - Ungheria 3
IQ - Iraq 3
LA - Repubblica Popolare Democratica del Laos 3
LT - Lituania 3
MW - Malawi 3
SA - Arabia Saudita 3
SM - San Marino 3
TW - Taiwan 3
UY - Uruguay 3
CL - Cile 2
EE - Estonia 2
KH - Cambogia 2
LY - Libia 2
MC - Monaco 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
BD - Bangladesh 1
BH - Bahrain 1
CO - Colombia 1
CR - Costa Rica 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
MD - Moldavia 1
Totale 16.868
Città #
Milan 1.018
Dublin 958
Rome 637
Chandler 573
Ann Arbor 474
Houston 473
Southend 446
Jacksonville 330
Singapore 312
New York 193
Toronto 183
The Dalles 165
Ashburn 153
Dearborn 142
Turin 134
Hong Kong 132
Beijing 120
Dong Ket 111
Wilmington 102
Naples 99
Frankfurt am Main 97
Helsinki 93
Lawrence 89
Boardman 82
Bologna 80
Moscow 80
Izmir 79
Boston 76
Modena 76
Woodbridge 66
Mountain View 65
Seoul 63
Florence 61
Redwood City 55
Tel Aviv 55
Los Angeles 54
Redmond 51
Genoa 45
Seattle 45
Jakarta 44
Padova 43
Brussels 42
Fairfield 40
Bari 34
Palermo 33
Catania 29
Washington 29
Brescia 28
Hefei 28
Munich 28
Palombara Sabina 28
Reggio Emilia 28
Verona 25
Duncan 24
Nanjing 24
Cambridge 21
Falls Church 21
Trieste 19
Council Bluffs 18
Dallas 18
Fremont 18
Nardò 18
Taranto 18
Bergamo 17
Treviso 17
Assago 16
Latina 15
London 15
Perugia 15
Pescara 15
Livorno 14
Ottawa 14
Parma 14
Vicenza 14
Falkenstein 13
Jinan 13
Kunming 13
Monza 13
Napoli 13
Shanghai 13
Guangzhou 12
Lappeenranta 12
Norwalk 12
Paris 12
Pisa 12
Sesto San Giovanni 12
Trento 12
Vienna 12
Amsterdam 11
Athens 11
Bucharest 11
Foggia 11
Nanchang 11
Novara 11
Rimini 11
Robbiate 11
Tirana 11
Torino 11
Venice 11
Auburn Hills 10
Totale 9.196
Nome #
Analisi dei costi della procedura angioplastica coronarica per via transradiale in regime ambulatoriale in Italia 4.956
La funzione di HTA nelle aziende sanitarie italiane: un potenziale ancora inutilizzato? 342
Prezzi di riferimento per dispositivi medici: criticità, vantaggi e approcci 319
Basic principles of health technology assessment, economic evaluation, and costing of healthcare programs 269
European Society of Cardiology: cardiovascular disease statistics 2019 256
Dinamiche economiche e performance del settore dei dispositivi medici in Italia 255
Programma nazionale HTA per dispositivi medici: quali sfide per l’implementazione? 223
Impatto del sistema di finanziamento a DRG sull’innovazione tecnologica in sanità. Il caso italiano 220
Financing medical devices in Italy and Spain 202
Economic evaluation of medical devices 190
Programma Nazionale di HTA per dispositivi medici: prove tecniche di implementazione 185
The economic crisis and acute myocardial infarction: new evidence using hospital-level data 182
Systematic literature review on the spread of health-related misinformation on social media 180
What factors drive heterogeneity of preferences for micro-health insurance in rural Malawi? 175
Understanding the impact of economic evidence on clinical decision making: a discrete choice experiment in cardiology 173
Myth #5: health care is rightly left to the private sector, for the sake of efficiency 160
The role of hospital payments in the adoption of new medical technologies: an international survey of current practice 159
Diffusion without evidence: a study on high-risk medical devices 153
Do social values and institutional context shape the use of economic evaluation in reimbursement decisions? An empirical analysis 151
Establishing a national HTA program for medical devices in Italy: overhauling a fragmented system to ensure value and equal access to new medical technologies 151
Assessing the outcomes of implantable cardioverter defibrillator treatment in a real world setting: results from hospital record data 144
Epidemiology of cardiovascular disease in Europe 142
Funding and Regulating Health Technologies in Decentralized Systems: A Comparison between Italy and Spain 140
Key reccomendations from the MedtecHTA project 140
Challenges in the assessment of medical devices: the MedtecHTA Project 140
Learning effect and diffusion of innovative medical devices: the case of transcatheter aortic valve implantation in Italy 140
Cost utility analysis of microprocessor controlled knee prosthesis in Italy 140
Sustainability of Universal Health Coverage: Five Continents, Four Perspectives 138
Direct costs of intracranial aneurysm treatment in the Italian hospitals 137
Does the approach to economic evaluation in health care depend on culture, values, and institutional context? 137
Comparing the efficiency of hospitals in Italy and Germany: nonparametric conditional approach based on partial frontier 133
HTA around the world: broadening our understanding of cross-country differences 133
Health care multidisciplinary teams: the sociotechnical approach for an integrated system-wide perspective 131
Does informal care impact utilization of healthcare services? Evidence from a longitudinal study of stroke patients 130
Il governo regionale dell'assistenza farmaceutica: un quadro delle iniziative adottate nel 2003 129
Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European project 128
Adoption decisions for medical devices in the field of cardiology: results from a European survey 128
Core outcome set in surgical oncology: why, what and how to measure 126
Inpatient reimbursement system in Italy: how do tariffs relate to costs? 125
Tariffe e finanziamento dell'innovazione tecnologica: analisi generale e focus su due casi regionali 125
Analisi dei costi di quattro strategie terapeutiche nella gestione di pazienti con broncopneumopatia (BPCO) moderata o severa: un'applicazione del modello bootstrap 123
I processi di valutazione dei dispositivi medici e delle tecnologie sanitarie 121
Financing medical devices: The case of implantable cardioverter defibrillators and coronary stents in Italy 121
Cost and reimbursement of cataract surgery in Europe: a cross country comparison 119
Impatto economico nella prospettiva del paziente: spese out-of-pocket, perdite di produttività e costi dell’assistenza informale 117
Assessing the added value of health technologies: reconciling different perspectives 115
Five year trends (2008-2012) in cardiac implantable electrical device utilization in five European nations: a case study in cross-country comparisons using administrative databases 115
Costing and performance in healthcare management 115
Should health technology assessment be more patient centric? If so, how? 114
Investigating the geographic disparity in quality of care: the case of hospital readmission after acute myocardial infarction in Italy 114
Diffusion and use of Health Technology Assessment in policy making: what lessons for decentralised healthcare systems? 112
Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal 111
Investigating regional variation of cardiac implantable electrical device implant rates in European healthcare systems: what drives differences? 110
At what cost is performance-based financing implemented? Novel evidence from Malawi 110
Cost-effectiveness of a programme of screening and brief interventions for alchool in primary care in Italy 108
Traveling for care: Inter-regional mobility for aortic valve substitution in Italy 107
Economic evaluation of user-fee exemption policies for maternal healthcare in Burkina Faso: evidence from a cost-effectiveness analysis 107
Generating appropriate clinical data for value assessment of medical devices: what role does regulation play? 106
Alcune riflessioni prima di tirare le somme 103
Incentivizing research into the effectiveness of medical devices 102
Coverage with evidence development for medical devices in Europe: can practice meet theory? 101
Expanding the role of early health economic modelling in evaluation of health technologies. Comment on "Problems and promises of health technologies: the role of early health economic modeling" 100
Uptake and diffusion of medical technology innovation in Europe: what role for funding and procurement policies? 99
What criteria guide national entrepreneurs' policy decisions on user fee removal for maternal health care services? Use of a best-worst scaling choice experiment in West Africa. 99
Explaining the health costs associated with managing intracranial aneurysms in Italy 98
The "Essential Levels of Care" in Italy: when being explicit serves the devolution of powers 95
Facts. Figures! Fiction? 95
The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study 94
Patient, hospital and country-level risk factors of all-cause mortality among patients with chronic heart failure: prospective international cohort study 94
Implant rates of cardiac implantable electrical devices in Europe: a systematic literature review 93
A new strategy for health and sustainable development in the light of the COVID-19 pandemic 93
Equità territoriale: definizioni, evidenze empiriche e politiche appropriate 88
Transformation of cancer care during and after the COVID pandemic, a point of no return : the experience of Italy 88
European Union regulation of health technology assessment: what is required for it to succeed? 88
Hospital cost of central line-associated bloodstream infections and cost-effectiveness of closed vs. open infusion containers. The case of Intensive Care Units in Italy 81
Economic Evaluation in Health Care: the Point of View of Informed Physicians 80
Evaluating complex health financing interventions: using mixed methods to inform further implementation of a novel PBI intervention in rural Malawi 78
A cohort study on diabetic undocumented migrants in Italy: can charitable organizations contribute to higher adherence? 77
Eliciting preferences to inform patient-centered policies: the case of psoriasis 77
Collecting physicians' preferences on medical devices: are we doing it right? Evidence from Italian orthopedists using 2 different stated preference methods 72
Healthcare services for undocumented migrants : organisation and costs from the Italian NHS perspective 71
Inequalities in avoidable hospitalisation in large urban areas: retrospective observational study in the metropolitan area of Milan 70
Prioritizing COVID-19 vaccine allocation in resource poor settings: towards an Artificial Intelligence-enabled and geospatial-assisted decision support framework 68
Blood donation in times of crisis: early insight into the impact of COVID‐19 on blood donors and their motivation to donate across European countries 68
Eliciting community preferences for complementary micro health insurance: A discrete choice experiment in rural Malawi. 67
Lifecycle evidence requirements for high-risk implantable medical devices: a European perspective 66
Risk communication during COVID-19: a descriptive study on familiarity with, adherence to and trust in the WHO preventive measures 64
Economic burden of cardiovascular diseases in the European Union: a population-based cost study 58
Investigating patients’ preferences to inform drug development decisions: novel Insights from a discrete choice experiment in migraine 58
Quo vadis HTA for medical devices in Central and Eastern Europe? Recommendations to address methodological challenges 57
How real can we get in generating real world evidence? Exploring the opportunities of routinely collected administrative data for evaluation of medical devices 54
Fact: Frailty can be prevented and treated 53
Real-world evidence in health technology assessment of high-risk medical devices: fit for purpose? 52
Psychometric evaluation of the Mental Health Quality of Life (MHQoL) instrument in seven European countries 52
Spillover effects and other determinants of medical device uptake in the presence of a medical guideline: an analysis of drug-eluting stents in Germany and Italy 51
Longitudinal associations between different measures of socioeconomic status and health behavior among adolescents. Data from a wealthy Italian region 50
A repeated cross-sectional analysis on the economic impact of SARS-CoV-2 pandemic at the hospital level in Italy 49
The role of technology and social media use in sleep-onset difficulties among Italian adolescents: cross-sectional study 48
Challenges of health technology assessment in pluralistic healthcare systems: an ISPOR council report 46
Public preferences for vaccination campaigns in the COVID-19 endemic phase: insights from the VaxPref database 44
Totale 16.773
Categoria #
all - tutte 61.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.808


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020266 0 0 0 0 0 0 0 0 0 0 115 151
2020/20211.720 121 140 89 175 198 153 160 64 158 126 134 202
2021/20221.635 79 209 54 59 119 63 100 197 150 188 205 212
2022/20233.744 234 222 103 300 242 274 180 264 1.341 167 248 169
2023/20243.050 175 139 188 150 239 382 317 327 158 241 362 372
2024/20253.858 247 131 305 273 302 290 409 329 1.003 442 127 0
Totale 17.204